|
1
|
Ostrom QT, Price M, Neff C, Cioffi G,
Waite KA, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical
report: Primary brain and other central nervous system tumors
diagnosed in the United States in 2015–2019. Neuro Oncol. 24 (Suppl
5):v1–v95. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu S, Tang L, Li X, Fan F and Liu Z:
Immunotherapy for glioma: Current management and future
application. Cancer Lett. 476:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu Y, Lang F and Yang C: NRF2 in human
neoplasm: Cancer biology and potential therapeutic target.
Pharmacol Ther. 217:1076642021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Asad AS, Candia AJN, González N, Zuccato
CF, Seilicovich A and Candolfi M: Current non-viral gene therapy
strategies for the treatment of glioblastoma. Curr Med Chem.
28:7729–7748. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shergalis A, Bankhead A III, Luesakul U,
Muangsin N and Neamati N: Current challenges and opportunities in
treating glioblastoma. Pharmacol Rev. 70:412–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang PH, Xu AM and White FM: Oncogenic
EGFR signaling networks in glioma. Sci Signal. 2:re62009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu H, Liu B, Hou X, Pang B, Guo P, Jiang
W, Ding Q, Zhang R, Xin T, Guo H, et al: Overexpression of
NIMA-related kinase 2 is associated with poor prognoses in
malignant glioma. J Neurooncol. 132:409–417. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiang J, Alafate W, Wu W, Wang Y, Li X,
Xie W, Bai X, Li R, Wang M and Wang J: NEK2 enhances malignancies
of glioblastoma via NIK/NF-κB pathway. Cell Death Dis. 13:582022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xia J, Franqui Machin R, Gu Z and Zhan F:
Role of NEK2A in human cancer and its therapeutic potentials.
Biomed Res Int. 2015:8624612015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Faragher AJ and Fry AM: Nek2A kinase
stimulates centrosome disjunction and is required for formation of
bipolar mitotic spindles. Mol Biol Cell. 14:2876–2889. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeong Y, Lee J, Kim K, Yoo JC and Rhee K:
Characterization of NIP2/centrobin, a novel substrate of Nek2, and
its potential role in microtubule stabilization. J Cell Sci.
120:2106–2116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhong X, Guan X, Liu W and Zhang L:
Aberrant expression of NEK2 and its clinical significance in
non-small cell lung cancer. Oncol Lett. 8:1470–1476. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu Z, Xia J, Xu H, Frech I, Tricot G and
Zhan F: NEK2 promotes aerobic glycolysis in multiple myeloma
through regulating splicing of pyruvate kinase. J Hematol Oncol.
10:172017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang X, Huang X, Xu J, Li E, Lao M, Tang
T, Zhang G, Guo C, Zhang X, Chen W, et al: NEK2 inhibition triggers
anti-pancreatic cancer immunity by targeting PD-L1. Nat Commun.
12:45362021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee J and Gollahon L: Mitotic
perturbations induced by Nek2 overexpression require interaction
with TRF1 in breast cancer cells. Cell Cycle. 12:3599–3614. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang Y and Zhang X: Targeting NEK2 as a
promising therapeutic approach for cancer treatment. Cell Cycle.
15:895–907. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qi C, Lei L, Hu J, Wang G, Liu J and Ou S:
Serine incorporator 2 (SERINC2) expression predicts an unfavorable
prognosis of low-grade glioma (LGG): Evidence from bioinformatics
analysis. J Mol Neurosci. 70:1521–1532. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pagano M, Pepperkok R, Verde F, Ansorge W
and Draetta G: Cyclin A is required at two points in the human cell
cycle. EMBO J. 11:961–971. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Murphy M, Stinnakre MG, Senamaud-Beaufort
C, Winston NJ, Sweeney C, Kubelka M, Carrington M, Bréchot C and
Sobczak-Thépot J: Delayed early embryonic lethality following
disruption of the murine cyclin A2 gene. Nat Genet. 15:83–86. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang A, Zhou Y, Gong W, Pan X, Gan X, Wu
Z, Liu B, Qu L and Wang L: CCNA2 as an immunological biomarker
encompassing tumor microenvironment and therapeutic response in
multiple cancer types. Oxid Med Cell Longev. 2022:59105752022.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Zhong Q, Li Z, Lin Z, Chen H and
Wang P: Integrated profiling identifies CCNA2 as a potential
biomarker of immunotherapy in breast cancer. Onco Targets Ther.
14:2433–2448. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Zhang Y, Zhou Y, Wang F, Yin C, Ding
L and Zhang S: Tanshinone IIA suppresses the progression of lung
adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1
pathway. Sci Rep. 11:236812021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gan Y, Li Y, Li T, Shu G and Yin G: CCNA2
acts as a novel biomarker in regulating the growth and apoptosis of
colorectal cancer. Cancer Manag Res. 10:5113–5124. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai Y and Yang W: PKMYT1 regulates the
proliferation and epithelial-mesenchymal transition of oral
squamous cell carcinoma cells by targeting CCNA2. Oncol Lett.
23:632022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bendris N, Arsic N, Lemmers B and
Blanchard JM: Cyclin A2, Rho GTPases and EMT. Small GTPases.
3:225–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Ying Y, Xie H, Jin K, Yan H, Wang S,
Xu M, Xu X, Wang X, Yang K, et al: Dual regulatory role of CCNA2 in
modulating CDK6 and MET-mediated cell-cycle pathway and EMT
progression is blocked by miR-381-3p in bladder cancer. FASEB J.
33:1374–1388. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Liu X, Zhou W, Lu S, Wu C, Wu Z,
Liu R, Li X, Wu J, Liu Y, et al: Identification of key genes
associated with the process of hepatitis B inflammation and cancer
transformation by integrated bioinformatics analysis. Front Genet.
12:6545172021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou Z, Cheng Y, Jiang Y, Liu S, Zhang M,
Liu J and Zhao Q: Ten hub genes associated with progression and
prognosis of pancreatic carcinoma identified by co-expression
analysis. Int J Biol Sci. 14:124–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao Z, Zhang KN, Wang Q, Li G, Zeng F,
Zhang Y, Wu F, Chai R, Wang Z, Zhang C, et al: Chinese glioma
genome atlas (CGGA): A comprehensive resource with functional
genomic data from Chinese glioma patients. Genomics Proteomics
Bioinformatics. 19:1–12. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cancer Genome Atlas Research Network, .
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome
atlas pan-cancer analysis project. Nat Genet. 45:1113–130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Neftel C, Laffy J, Filbin MG, Hara T,
Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM,
et al: An integrative model of cellular states, plasticity, and
genetics for glioblastoma. Cell. 178:835–849.e21. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Satija R, Farrell JA, Gennert D, Schier AF
and Regev A: Spatial reconstruction of single-cell gene expression
data. Nat Biotechnol. 33:495–502. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aran D, Looney AP, Liu L, Wu E, Fong V,
Hsu A, Chak S, Naikawadi RP, Wolters PJ, Abate AR, et al:
Reference-based analysis of lung single-cell sequencing reveals a
transitional profibrotic macrophage. Nat Immunol. 20:163–172. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu C, Li T, Xu Y, Zhang X, Li F, Bai J,
Chen J, Jiang W, Yang K, Ou Q, et al: CellMarker 2.0: An updated
database of manually curated cell markers in human/mouse and web
tools based on scRNA-seq data. Nucleic Acids Res. 51(D1):
D870–D876. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, Wang ZX, Chen YX, Wu HX, Yin L,
Zhao Q, Luo HY, Zeng ZL, Qiu MZ and Xu RH: Integrated analysis of
single-cell and bulk RNA sequencing data reveals a pan-cancer
stemness signature predicting immunotherapy response. Genome Med.
14:452022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Trapnell C, Cacchiarelli D, Grimsby J,
Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS and
Rinn JL: The dynamics and regulators of cell fate decisions are
revealed by pseudotemporal ordering of single cells. Nat
Biotechnol. 32:381–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zheng SC, Stein-O'Brien G, Augustin JJ,
Slosberg J, Carosso GA, Winer B, Shin G, Bjornsson HT, Goff LA and
Hansen KD: Universal prediction of cell-cycle position using
transfer learning. Genome Biol. 23:412022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liberzon A, Birger C, Thorvaldsdóttir H,
Ghandi M, Mesirov JP and Tamayo P: The Molecular signatures
database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Patel AP, Tirosh I, Trombetta JJ, Shalek
AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT,
Martuza RL, et al: Single-cell RNA-seq highlights intratumoral
heterogeneity in primary glioblastoma. Science. 344:1396–1401.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Querec TD, Akondy RS, Lee EK, Cao W,
Nakaya HI, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, et al:
Systems biology approach predicts immunogenicity of the yellow
fever vaccine in humans. Nat Immunol. 10:116–125. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kinoshita M, Uchida T, Sato A, Nakashima
M, Nakashima H, Shono S, Habu Y, Miyazaki H, Hiroi S and Seki S:
Characterization of two F4/80-positive Kupffer cell subsets by
their function and phenotype in mice. J Hepatol. 53:903–910. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang L, Li Z, Skrzypczynska KM, Fang Q,
Zhang W, O'Brien SA, He Y, Wang L, Zhang Q, Kim A, et al:
Single-cell analyses inform mechanisms of myeloid-targeted
therapies in colon cancer. Cell. 181:442–459.e29. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Haber AL, Biton M, Rogel N, Herbst RH,
Shekhar K, Smillie C, Burgin G, Delorey TM, Howitt MR, Katz Y, et
al: A single-cell survey of the small intestinal epithelium.
Nature. 551:333–339. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiu J, Qu X, Wang Y, Guo C, Lv B, Jiang Q,
Su W, Wang L and Hua K: Single-cell landscape highlights
heterogenous microenvironment, novel immune reaction patterns,
potential biomarkers and unique therapeutic strategies of cervical
squamous carcinoma, human papillomavirus-associated (HPVA) and
non-HPVA adenocarcinoma. Adv Sci (Weinh). 10:e22049512023.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
van der Poel M, Ulas T, Mizee MR, Hsiao
CC, Miedema SSM, Adelia Schuurman KG, Helder B, Tas SW, Schultze
JL, et al: Transcriptional profiling of human microglia reveals
grey-white matter heterogeneity and multiple sclerosis-associated
changes. Nat Commun. 10:11392019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bassez A, Vos H, Van Dyck L, Floris G,
Arijs I, Desmedt C, Boeckx B, Vanden Bempt M, Nevelsteen I, Lambein
K, et al: A single-cell map of intratumoral changes during anti-PD1
treatment of patients with breast cancer. Nat Med. 27:820–832.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wendisch D, Dietrich O, Mari T, von
Stillfried S, Ibarra IL, Mittermaier M, Mache C, Chua RL, Knoll R,
Timm S, et al: SARS-CoV-2 infection triggers profibrotic macrophage
responses and lung fibrosis. Cell. 184:6243–6261.e27. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gong Z, Li Q, Shi J, Li P, Hua L, Shultz
LD and Ren G: Immunosuppressive reprogramming of neutrophils by
lung mesenchymal cells promotes breast cancer metastasis. Sci
Immunol. 8:eadd52042023. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kennedy A, Waters E, Rowshanravan B, Hinze
C, Williams C, Janman D, Fox TA, Booth C, Pesenacker AM, Halliday
N, et al: Differences in CD80 and CD86 transendocytosis reveal CD86
as a key target for CTLA-4 immune regulation. Nat Immunol.
23:1365–1378. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Amiry-Moghaddam M: AQP4 and the fate of
gliomas. Cancer Res. 79:2810–2811. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hu H, Mu Q, Bao Z, Chen Y, Liu Y, Chen J,
Wang K, Wang Z, Nam Y, Jiang B, et al: Mutational landscape of
secondary glioblastoma guides MET-targeted trial in brain tumor.
Cell. 175:1665–1678.e18. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kakogiannos N, Ferrari L, Giampietro C,
Scalise AA, Maderna C, Ravà M, Taddei A, Lampugnani MG, Pisati F,
Malinverno M, et al: JAM-A acts via C/EBP-α to promote claudin-5
expression and enhance endothelial barrier function. Circ Res.
127:1056–1073. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hosmann A, Jaber M, Roetzer-Pejrimovsky T,
Timelthaler G, Borkovec M, Kiesel B, Wadiura LI, Millesi M, Mercea
PA, Phillips J, et al: CD34 microvascularity in low-grade glioma:
Correlation with 5-aminolevulinic acid fluorescence and patient
prognosis in a multicenter study at three specialized centers. J
Neurosurg. 138:1281–1290. 20232PubMed/NCBI
|
|
55
|
Agostini M, Amato F, Vieri ML, Greco G,
Tonazzini I, Baroncelli L, Caleo M, Vannini E, Santi M, Signore G
and Cecchini M: Glial-fibrillary-acidic-protein (GFAP) biomarker
detection in serum-matrix: Functionalization strategies and
detection by an ultra-high-frequency surface-acoustic-wave
(UHF-SAW) lab-on-chip. Biosens Bioelectron. 172:1127742021.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Gai QJ, Fu Z, He J, Mao M, Yao XX, Qin Y,
Lan X, Zhang L, Miao JY, Wang YX, et al: EPHA2 mediates PDGFA
activity and functions together with PDGFRA as prognostic marker
and therapeutic target in glioblastoma. Signal Transduct Target
Ther. 7:332022. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Suvà ML, Rheinbay E, Gillespie SM, Patel
AP, Wakimoto H, Rabkin SD, Riggi N, Chi AS, Cahill DP, Nahed BV, et
al: Reconstructing and reprogramming the tumor-propagating
potential of glioblastoma stem-like cells. Cell. 157:580–594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yang Y, Chu L, Zeng Z, Xu S, Yang H, Zhang
X, Jia J, Long N, Hu Y and Liu J: Four specific biomarkers
associated with the progression of glioblastoma multiforme in older
adults identified using weighted gene co-expression network
analysis. Bioengineered. 12:6643–6654. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bendris N, Loukil A, Cheung C, Arsic N,
Rebouissou C, Hipskind R, Peter M, Lemmers B and Blanchard JM:
Cyclin A2: A genuine cell cycle regulator? Biomol Concepts.
3:535–543. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Loukil A, Cheung CT, Bendris N, Lemmers B,
Peter M and Blanchard JM: Cyclin A2: At the crossroads of cell
cycle and cell invasion. World J Biol Chem. 6:346–350. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liang W, Guan H, He X, Ke W, Xu L, Liu L,
Xiao H and Li Y: Down-regulation of SOSTDC1 promotes thyroid cancer
cell proliferation via regulating cyclin A2 and cyclin E2.
Oncotarget. 6:31780–31791. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Andersen JS, Wilkinson CJ, Mayor T,
Mortensen P, Nigg EA and Mann M: Proteomic characterization of the
human centrosome by protein correlation profiling. Nature.
426:570–574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
O'regan L, Blot J and Fry AM: Mitotic
regulation by NIMA-related kinases. Cell Div. 2:252007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Huang X, Zhang G, Tang T, Gao X and Liang
T: One shoot, three birds: Targeting NEK2 orchestrates
chemoradiotherapy, targeted therapy, and immunotherapy in cancer
treatment. Biochim Biophys Acta Rev Cancer. 1877:1886962022.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Alcantara Llaguno S, Chen J, Kwon CH,
Jackson EL, Li Y, Burns DK, Alvarez-Buylla A and Parada LF:
Malignant astrocytomas originate from neural stem/progenitor cells
in a somatic tumor suppressor mouse model. Cancer Cell. 15:45–56.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Liu C, Sage JC, Miller MR, Verhaak RG,
Hippenmeyer S, Vogel H, Foreman O, Bronson RT, Nishiyama A, Luo L
and Zong H: Mosaic analysis with double markers reveals tumor cell
of origin in glioma. Cell. 146:209–221. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hydbring P, Malumbres M and Sicinski P:
Non-canonical functions of cell cycle cyclins and cyclin-dependent
kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Huang J, Li Q, Peng Q, Xie Y, Wang W, Pei
C, Zhao Y, Liu R, Huang L, Li T, et al: Single-cell RNA sequencing
reveals heterogeneity and differential expression of decidual
tissues during the peripartum period. Cell Prolif. 54:e129672021.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhao T, Fu Y, Zhu J, Liu Y, Zhang Q, Yi Z,
Chen S, Jiao Z, Xu X, Xu J, et al: Single-cell RNA-Seq reveals
dynamic early embryonic-like programs during chemical
reprogramming. Cell Stem Cell. 23:31–45.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Balducci M, Chiesa S, Diletto B,
D'Agostino GR, Mangiola A, Manfrida S, Mantini G, Albanese A,
Fiorentino A, Frascino V, et al: Low-dose fractionated radiotherapy
and concomitant chemotherapy in glioblastoma multiforme with poor
prognosis: A feasibility study. Neuro Oncol. 14:79–86. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kong L, Gao J, Hu J, Lu R, Yang J, Qiu X,
Hu W and Lu JJ: Carbon ion radiotherapy boost in the treatment of
glioblastoma: A randomized phase I/III clinical trial. Cancer
Commun (Lond). 39:52019.PubMed/NCBI
|
|
72
|
Kops GJ, Weaver BA and Cleveland DW: On
the road to cancer: Aneuploidy and the mitotic checkpoint. Nat Rev
Cancer. 5:773–785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Nicholson JM and Cimini D: How mitotic
errors contribute to karyotypic diversity in cancer. Adv Cancer
Res. 112:43–75. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Fry AM, O'Regan L, Sabir SR and Bayliss R:
Cell cycle regulation by the NEK family of protein kinases. J Cell
Sci. 125:4423–4433. 2012.PubMed/NCBI
|
|
75
|
Fry AM, Meraldi P and Nigg EA: A
centrosomal function for the human Nek2 protein kinase, a member of
the NIMA family of cell cycle regulators. EMBO J. 17:470–481. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Li JJ and Li SA: Mitotic kinases: the key
to duplication, segregation, and cytokinesis errors, chromosomal
instability, and oncogenesis. Pharmacol Ther. 111:974–984. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Helps NR, Luo X, Barker HM and Cohen PT:
NIMA-related kinase 2 (Nek2), a cell-cycle-regulated protein kinase
localized to centrosomes, is complexed to protein phosphatase 1.
Biochem J. 349:509–518. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Chotiner JY, Wolgemuth DJ and Wang PJ:
Functions of cyclins and CDKs in mammalian gametogenesis†. Biol
Reprod. 101:591–601. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Jiang F, Luo F, Zeng N, Mao Y, Tang X,
Wang J, Hu Y and Wu C: Characterization of fatty acid
metabolism-related genes landscape for predicting prognosis and
aiding immunotherapy in glioma patients. Front Immunol.
13:9021432022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Sturm D, Pfister SM and Jones DTW:
Pediatric gliomas: Current concepts on diagnosis, biology, and
clinical management. J Clin Oncol. 35:2370–2377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ashby LS and Ryken TC: Management of
malignant glioma: Steady progress with multimodal approaches.
Neurosurg Focus. 20:E32006. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Andersen BM, Faust Akl C, Wheeler MA,
Chiocca EA, Reardon DA and Quintana FJ: Glial and myeloid
heterogeneity in the brain tumour microenvironment. Nat Rev Cancer.
21:786–802. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Martínez-Cerdeño V and Noctor SC: Neural
progenitor cell terminology. Front Neuroanat. 12:1042018.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhu Y, Guignard F, Zhao D, Liu L, Burns
DK, Mason RP, Messing A and Parada LF: Early inactivation of p53
tumor suppressor gene cooperating with NF1 loss induces malignant
astrocytoma. Cancer Cell. 8:119–130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zarco N, Norton E, Quiñones-Hinojosa A and
Guerrero-Cázares H: Overlapping migratory mechanisms between neural
progenitor cells and brain tumor stem cells. Cell Mol Life Sci.
76:3553–3570. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zheng H, Ying H, Yan H, Kimmelman AC,
Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, et al: p53
and Pten control neural and glioma stem/progenitor cell renewal and
differentiation. Nature. 455:1129–1133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Jung E, Alfonso J, Osswald M, Monyer H,
Wick W and Winkler F: Emerging intersections between neuroscience
and glioma biology. Nat Neurosci. 22:1951–1960. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Schonberg DL, Lubelski D, Miller TE and
Rich JN: Brain tumor stem cells: Molecular characteristics and
their impact on therapy. Mol Aspects Med. 39:82–101. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kohwi M and Doe CQ: Temporal fate
specification and neural progenitor competence during development.
Nat Rev Neurosci. 14:823–838. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yabo YA, Niclou SP and Golebiewska A:
Cancer cell heterogeneity and plasticity: A paradigm shift in
glioblastoma. Neuro Oncol. 24:669–682. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Liu L, Michowski W, Kolodziejczyk A and
Sicinski P: The cell cycle in stem cell proliferation, pluripotency
and differentiation. Nat Cell Biol. 21:1060–1067. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Meacham CE and Morrison SJ: Tumour
heterogeneity and cancer cell plasticity. Nature. 501:328–337.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Roninson IB, Broude EV and Chang BD: If
not apoptosis, then what? Treatment-induced senescence and mitotic
catastrophe in tumor cells. Drug Resist Updat. 4:303–313. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Castro-Gamero AM, Pezuk JA, Brassesco MS
and Tone LG: G2/M inhibitors as pharmacotherapeutic opportunities
for glioblastoma: The old, the new, and the future. Cancer Biol
Med. 15:354–374. 2018. View Article : Google Scholar : PubMed/NCBI
|
